Literature DB >> 4077554

False-positive and false-negative neck nodes.

S Ali, R M Tiwari, G B Snow.   

Abstract

We report our experience of the incidence of false-positive (i.e., clinically positive and histologically negative) and false-negative (i.e., clinically negative and histologically positive) neck nodes and define their relationship to the primary site, T-stage, and the histologic grade of the primary lesion. Clinical and pathologic records of 255 patients with squamous cell carcinoma (SCC) of the head and neck who underwent 266 radical neck dissections were reviewed. We did not find any relationship between the T-stage of the primary tumor and the incidence of the false-positive and false-negative neck nodes. Regarding the primary site, the benefit of an elective neck dissection is likely to be maximum in oropharyngeal SCC and minimum in supraglottic SCC. The incidence of false-negative neck nodes was lower in well differentiated primary lesions.

Entities:  

Mesh:

Year:  1985        PMID: 4077554     DOI: 10.1002/hed.2890080204

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  18 in total

Review 1.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Neck dissection alternatives.

Authors:  R M Tiwari
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1997-10

Review 3.  Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx.

Authors:  R Böscke; B D Cakir; A S Hoffmann; S Wiegand; J Quetz; J E Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-10       Impact factor: 2.503

4.  Pet-FDG imaging in the clinical evaluation of head and neck cancer.

Authors:  W L Wong; E Chevretton; M McGurk; D Croft
Journal:  J R Soc Med       Date:  1995-08       Impact factor: 5.344

5.  Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study.

Authors:  M W van den Brekel; J A Castelijns; H V Stel; R P Golding; C J Meyer; G B Snow
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

6.  Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?

Authors:  Jolijn Brouwer; Remco de Bree; Emile F I Comans; Jonas A Castelijns; Otto S Hoekstra; C René Leemans
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

7.  [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.

Authors:  S Dresel; J Grammerstorff; K Schwenzer; K Brinkbäumer; R Schmid; T Pfluger; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-09       Impact factor: 9.236

Review 8.  Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.

Authors:  J Quak; G van Dongen
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

9.  Diagnostic Efficacy of Computed Tomography in Detecting Cervical Metastases in Clinically N0 Head and Neck Squamous Cell Carcinoma.

Authors:  Eishaan K Bhargava; Praveen K Rathore; Anoop Raj; Ravi Meher; Kanika Rana
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-02-08

Review 10.  Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Authors:  Hubert Vermeersch; David Loose; Hamphrey Ham; Andreas Otte; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.